IPO - Little Green Pharma Ltd, page-113

Find it baffling that LGP can be valued by the market lower than AusCann (AC8). Here is my quick comparison between the two. Am I missing something? Seems to me LGP is undervalued.

LGP v AusCann

Market Cap

$51m v $73m

2H 2020 Revenue

$716k v zero

Growth rate

20% per month v zero

2H 2020 Burn Rate

$4.1m v $3.4m

Products in Market

4 v 0

Cash on Hand

~$10m v $26m

Production Capacity and Timing

LGP: 110,000 bottles or 1750kg of dried flower per annum to commence in 2Q 2020. Current capacity is ~200-250kg / annum??

AusCann: none - all outsourced

Breakeven expectations

3Q 2020 v no timeline given